CCM
GDRX icon

Chimera Capital Management’s GoodRx Holdings GDRX Stock Holding History

Chimera Capital Management’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-55,749
Closed -$260K – 131
2022
Q4 		$260K Sell
55,749
-248,856
-82% -$1.23M 0.07% 172
2022
Q3 		$1.42M Buy
+304,605
New +$1.92M 0.4% 48

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $361M AUM 30.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Silver Lake Group
Silver Lake Group Menlo Park, California $4.58B AUM 24.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
PTC
Petrus Trust Company Dallas, Texas $1.06B AUM 4.66% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OrbiMed
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
TCMX
Technology Crossover Management X Menlo Park, California $795M AUM 5.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Chimera Capital Management's GDRX Position: Q1 2023 in Review

Chimera Capital Management sold out of GoodRx Holdings (GDRX) in Q1 2023, closing a stake of 55,749 shares — an estimated $260K sold.

Chimera Capital Management first reported a position in GDRX in Q3 2022 and held it in 2 quarters. The position peaked at $1.42M in Q3 2022. 159 funds tracked by Wall St. Rank hold GDRX as of Q1 2023.

  • Chimera Capital Management reported no remaining GoodRx Holdings position as of Q1 2023 after selling out during the quarter.
  • Chimera Capital Management sold 55,749 GoodRx Holdings shares in Q1 2023, an estimated $260K.
  • Chimera Capital Management first reported a position in GoodRx Holdings in Q3 2022 and held it in 2 quarters.
  • Chimera Capital Management's GoodRx Holdings position peaked at $1.42M in Q3 2022.
  • 159 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2023.

Based on Chimera Capital Management's 13F filing for Q1 2023, filed 15 May 2023.